Han Ji Hyuk, Kim Sung Huhn, Moon In Seok, Joo Sun Young, Kim Jung Ah, Gee Heon Yung, Jung Jinsei, Choi Jae Young
Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Institute for Yonsei Ear Science, Seoul, Republic of Korea.
Ear Hear. 2023;44(1):223-231. doi: 10.1097/AUD.0000000000001269. Epub 2022 Aug 15.
Despite growing interest in the genetic contribution to cochlear implant (CI) outcomes, only a few studies with limited samples have examined the association of CI outcomes with genetic etiologies. We analyzed CI outcomes using known predictors and genetic testing results to obtain a comprehensive understanding of the impact of genetic etiologies.
We retrospectively reviewed the medical records and images of patients who underwent cochlear implantation and genetic testing at a single tertiary medical institution, between May 2008 and December 2020. After excluding those whose speech test results were unavailable, and those in whom the implant was removed due to complications, such as infection or device failure, 203 patients were included in this study. The participants were categorized into adult (≥19 years), child (2-18 years), and infant (<24 months) groups. Outcomes were measured based on categories of auditory perception, monosyllable, disyllable, and sentence scores. For the infant group, the Infant-Toddler Meaningful Auditory Integration Scale score was used.
Among the 203 participants, a causative genetic variant was identified in 117 (57.6%) individuals. The presence of a causative variant was significantly associated with better CI outcomes in the infant group (β = 0.23; 95% confidence interval, 0.01 to 0.47; p = 0.044), but not in the child and adult groups. In the genetically confirmed patients without cochlear malformation, genetic variants involving the spiral ganglion was a poor prognostic factor in the child group (β = -57.24; 95% confidence interval, -90.63 to -23.75; p = 0.004).
The presence of known genetic etiology of hearing loss was associated with better CI outcomes in the infant group, but not in the child and adult groups. A neural-type genetic variant was a poor prognostic factor in the genetically diagnosed child subgroup without cochlear malformation. Careful genetic counseling should be performed before cochlear implantation.
尽管人们对基因因素对人工耳蜗(CI)植入效果的影响越来越感兴趣,但仅有少数样本量有限的研究探讨了CI植入效果与基因病因之间的关联。我们使用已知的预测因素和基因检测结果分析CI植入效果,以全面了解基因病因的影响。
我们回顾性分析了2008年5月至2020年12月期间在一家三级医疗机构接受人工耳蜗植入和基因检测的患者的病历和影像资料。排除那些无法获得言语测试结果的患者,以及因感染或设备故障等并发症而取出植入物的患者后,本研究纳入了203例患者。参与者被分为成人(≥19岁)、儿童(2 - 18岁)和婴儿(<24个月)组。根据听觉感知、单音节、双音节和句子得分类别来衡量植入效果。对于婴儿组,使用婴幼儿有意义听觉整合量表得分。
在203名参与者中,117名(57.6%)个体被鉴定出有致病基因变异。致病变异的存在与婴儿组更好的CI植入效果显著相关(β = 0.23;95%置信区间,0.01至0.47;p = 0.044),但在儿童和成人组中并非如此。在基因确诊且无耳蜗畸形的患者中,涉及螺旋神经节的基因变异是儿童组预后不良的因素(β = -57.24;95%置信区间,-90.63至-23.75;p = 0.004)。
已知的听力损失基因病因与婴儿组更好的CI植入效果相关,但在儿童和成人组中并非如此。在基因诊断且无耳蜗畸形的儿童亚组中,神经型基因变异是预后不良的因素。人工耳蜗植入前应进行仔细的遗传咨询。